Nine for 2021: Addressing the pandemic legacyIn this second ‘Nine for 2021‘ article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact Share XNine for 2021: Addressing the pandemic legacyhttps://pharmaphorum.com/views-analysis-sales-marketing/nine-for-2021-pandemic-legacy/
Sanofi preps trials of second COVID-19 shot, as Russia approves anotherSanofi will shortly start human trials of a second coronavirus vaccine, developed with US biotech Translate Bio, after Share XSanofi preps trials of second COVID-19 shot, as Russia approves anotherhttps://pharmaphorum.com/news/sanofi-preps-trials-of-second-covid-19-shot-as-russia-approves-another/
China starts vaccinating key workers against COVID-19; reportChina has already granted emergency use authorisation to multiple COVID-19 vaccines developed by domestic drugmakers and started dosing Share XChina starts vaccinating key workers against COVID-19; reporthttps://pharmaphorum.com/news/chinese-starts-vaccinating-key-workers-against-covid-19-report/
Bayer slides on €9.5bn loss caused by litigation, COVID-19 impactBayer counted the cost of its expensive Roundup weedkiller settlement in the second quarter with a €9.5 billion Share XBayer slides on €9.5bn loss caused by litigation, COVID-19 impacthttps://pharmaphorum.com/news/bayer-slides-on-e9-5bn-loss-caused-by-litigation-covid-19-impact/
BI opens second branch of digital lab in ChinaBoehringer Ingelheim has announced that it will open a second branch of its digital lab, BI X, in Share XBI opens second branch of digital lab in Chinahttps://pharmaphorum.com/news/bi-opens-branch-of-digital-lab-in-china/
Does pharma’s future lie in China?Healthcare innovation has a long history in effective collaboration, whether that’s across academia and industry or borders. Some Share XDoes pharma’s future lie in China?https://pharmaphorum.com/r-d/views-analysis-r-d/does-pharmas-future-lie-in-china/
Vifor forges iron drug partnership with Fresenius in ChinaVifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency Share XVifor forges iron drug partnership with Fresenius in Chinahttps://pharmaphorum.com/news/vifor-forges-iron-drug-partnership-with-fresenius-in-china/
Nine pharma trends for 2020Sarah Rickwood looks back at how pharma changed over the last decade and what this might mean for Share XNine pharma trends for 2020https://pharmaphorum.com/views-analysis-digital/nine-pharma-trends-for-2020/
China’s Adagene raises $69m for cancer immunotherapiesChinese biotech Adagene has raised $69 million in fourth-round financing to help usher its immuno-oncology drugs – including Share XChina’s Adagene raises $69m for cancer immunotherapieshttps://pharmaphorum.com/news/chinas-adagene-raises-69m-for-cancer-immunotherapies/
